Crinetics Pharmaceuticals, Inc. — All Filings
655 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001041 | Mar 26, 2026 | — |
| 8-K | 8-K | 0001658247-26-000020 | Mar 23, 2026 | Mar 17, 2026 |
| 4 | FORM 4 | 0001628280-26-019503 | Mar 18, 2026 | Mar 16, 2026 |
| 4 | FORM 4 | 0001628280-26-019498 | Mar 18, 2026 | Mar 16, 2026 |
| 4 | FORM 4 | 0001628280-26-019488 | Mar 18, 2026 | Mar 16, 2026 |
| 144 | — | 0001950047-26-002789 | Mar 18, 2026 | — |
| 144 | — | 0001628280-26-017947 | Mar 16, 2026 | — |
| 144 | — | 0001628280-26-017948 | Mar 16, 2026 | — |
| 144 | — | 0001628280-26-017946 | Mar 16, 2026 | — |
| 4 | FORM 4 | 0001628280-26-017797 | Mar 13, 2026 | Mar 12, 2026 |
| 144 | — | 0001950047-26-002543 | Mar 12, 2026 | — |
| 4 | FORM 4 | 0001628280-26-014775 | Mar 4, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001628280-26-014772 | Mar 4, 2026 | Mar 3, 2026 |
| 8-K | 8-K | 0001658247-26-000017 | Mar 3, 2026 | Feb 27, 2026 |
| 144 | — | 0001950047-26-002102 | Mar 3, 2026 | — |
| 144 | — | 0001628280-26-013047 | Mar 2, 2026 | — |
| S-8 | S-8 | 0001658247-26-000014 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001658247-26-000012 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001658247-26-000011 | Feb 26, 2026 | — |
| 4 | FORM 4 | 0001628280-26-011730 | Feb 25, 2026 | Feb 23, 2026 |
| 4 | FORM 4 | 0001628280-26-011715 | Feb 25, 2026 | Feb 23, 2026 |
| 4 | FORM 4 | 0001628280-26-011718 | Feb 25, 2026 | Feb 23, 2026 |
| 4 | FORM 4 | 0001628280-26-011723 | Feb 25, 2026 | Feb 23, 2026 |
| 4 | FORM 4 | 0001628280-26-011728 | Feb 25, 2026 | Feb 23, 2026 |
| SCHEDULE 13G/A | — | 0000908834-26-000040 | Feb 5, 2026 | — |
| 144 | — | 0001950047-26-000824 | Feb 2, 2026 | — |
| 8-K | 8-K | 0001658247-26-000003 | Jan 26, 2026 | Jan 20, 2026 |
| 8-K | 8-K | 0001193125-26-011872 | Jan 13, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-006276 | Jan 7, 2026 | — |
| 8-K | 8-K | 0001193125-26-006421 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001628280-26-001230 | Jan 7, 2026 | Jan 5, 2026 |
| 144 | — | 0001950047-26-000146 | Jan 5, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-002458 | Jan 5, 2026 | — |
| 8-K | 8-K | 0001193125-26-002368 | Jan 5, 2026 | — |
| 144 | — | 0001950047-26-000066 | Jan 2, 2026 | — |
| 4 | FORM 4 | 0001628280-25-059009 | Dec 29, 2025 | Dec 26, 2025 |
| 4 | FORM 4 | 0001628280-25-058056 | Dec 18, 2025 | — |
| 8-K | 8-K | 0001658247-25-000022 | Dec 17, 2025 | Dec 16, 2025 |
| 4 | FORM 4 | 0001628280-25-055054 | Dec 3, 2025 | Dec 1, 2025 |
| 144 | — | 0001950047-25-009572 | Dec 1, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000398 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001658247-25-000019 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001658247-25-000018 | Nov 6, 2025 | — |
| 4 | FORM 4 | 0001628280-25-049671 | Nov 5, 2025 | Nov 3, 2025 |
| 144 | — | 0001950047-25-008396 | Nov 3, 2025 | — |
| 4 | FORM 4 | 0001658247-25-000013 | Oct 3, 2025 | Oct 1, 2025 |
| 144 | — | 0001950047-25-007645 | Oct 1, 2025 | — |
| 4 | FORM 4 | 0001658247-25-000010 | Sep 30, 2025 | Sep 26, 2025 |
| 4 | FORM 4 | 0001658247-25-000011 | Sep 30, 2025 | Sep 26, 2025 |
| 144 | — | 0001950047-25-007529 | Sep 26, 2025 | — |